Many studies have focused on identifying genes as biomarkers associated with tumor response and survival prognosis of rectal cancer patients with pCRT, such as SERPINB5, CHD4, TCN1, VNN1, EPHA4, PCSK1, and DUOX2 genes [8–14]. This evidence concerns the gene CHD4 and rectal cancer.